Literature DB >> 8073289

Prophylactic vaccines, risk behavior change, and the probability of eradicating HIV in San Francisco.

S M Blower1, A R McLean.   

Abstract

Theory is linked with data to assess the probability of eradicating human immunodeficiency virus (HIV) in San Francisco through the use of prophylactic vaccines. The necessary vaccine efficacy levels and population coverage levels for eradication are quantified. The likely impact of risk behavior changes on vaccination campaigns is assessed. The results show it is unlikely that vaccines will be able to eradicate HIV in San Francisco unless they are combined with considerable reductions in risk behaviors. Furthermore, if risk behavior increases as the result of a vaccination campaign, then vaccination could result in a perverse outcome by increasing the severity of the epidemic.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8073289     DOI: 10.1126/science.8073289

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  41 in total

Review 1.  The economics of HIV vaccines: projecting the impact of HIV vaccination of infants in sub-Saharan Africa.

Authors:  J M Bos; M J Postma
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

2.  Beneficial and perverse effects of isoniazid preventive therapy for latent tuberculosis infection in HIV-tuberculosis coinfected populations.

Authors:  Ted Cohen; Marc Lipsitch; Rochelle P Walensky; Megan Murray
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-21       Impact factor: 11.205

3.  Imperfect vaccination: some epidemiological and evolutionary consequences.

Authors:  Sylvain Gandon; Margaret Mackinnon; Sean Nee; Andrew Read
Journal:  Proc Biol Sci       Date:  2003-06-07       Impact factor: 5.349

Review 4.  Modelling the influence of human behaviour on the spread of infectious diseases: a review.

Authors:  Sebastian Funk; Marcel Salathé; Vincent A A Jansen
Journal:  J R Soc Interface       Date:  2010-05-26       Impact factor: 4.118

5.  A susceptible-infected epidemic model with voluntary vaccinations.

Authors:  Frederick H Chen
Journal:  J Math Biol       Date:  2006-06-07       Impact factor: 2.259

6.  Demand forecasting for preventive AIDS vaccines: economic and policy dimensions.

Authors:  Robert Hecht; Gian Gandhi
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981

7.  HIV vaccine knowledge and beliefs among communities at elevated risk: conspiracies, questions and confusion.

Authors:  Kathleen Johnston Roberts; Peter A Newman; Naihua Duan; Ellen T Rudy
Journal:  J Natl Med Assoc       Date:  2005-12       Impact factor: 1.798

8.  Effects of contact network structure on epidemic transmission trees: implications for data required to estimate network structure.

Authors:  Nicole Bohme Carnegie
Journal:  Stat Med       Date:  2017-02-13       Impact factor: 2.373

9.  Declines in HIV prevalence can be associated with changing sexual behaviour in Uganda, urban Kenya, Zimbabwe, and urban Haiti.

Authors:  T B Hallett; J Aberle-Grasse; G Bello; L-M Boulos; M P A Cayemittes; B Cheluget; J Chipeta; R Dorrington; S Dube; A K Ekra; J M Garcia-Calleja; G P Garnett; S Greby; S Gregson; J T Grove; S Hader; J Hanson; W Hladik; S Ismail; S Kassim; W Kirungi; L Kouassi; A Mahomva; L Marum; C Maurice; M Nolan; T Rehle; J Stover; N Walker
Journal:  Sex Transm Infect       Date:  2006-04       Impact factor: 3.519

10.  Acceptability of PrEP Uptake Among Racially/Ethnically Diverse Young Men Who Have Sex With Men: The P18 Study.

Authors:  Rafael E Pérez-Figueroa; Farzana Kapadia; Staci C Barton; Jessica A Eddy; Perry N Halkitis
Journal:  AIDS Educ Prev       Date:  2015-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.